Zydus gets USFDA nod for seizure, migraine drug Ruby Khatun Khatun28 Nov 2017 1:53 PM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Topiramate extended-release capsules,...
Zydus Cadila gets USFDA nod to sell erectile dysfunction drug Ruby Khatun Khatun24 Nov 2017 11:05 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received approval from the US health regulator to market Tadalafil tablets, used for the treatment of...
Zydus Cadila gets USFDA nod for swelling reducing drug Ruby Khatun Khatun20 Nov 2017 10:02 AM ISTNew Delhi: Zydus Cadila has received final approval from the US health regulator to market Ethacrynate sodium for injection, used to reduce swelling...
Zydus Cadila, Intas Pharma under CDSCO scanner for launching Unapproved drug Ruby Khatun Khatun10 Nov 2017 4:24 PM ISTNew Delhi: The Central Drug Standards Control Organization (CDSCO) has initiated an inquiry against the two domestic drug makers Zydus Cadila and...
Zydus gets USFDA nod for overactive bladder drug Ruby Khatun Khatun6 Oct 2017 9:49 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market capsules used in treating overactive...
Zydus gets USFDA nod to market anti-diuretic nasal spray Ruby Khatun Khatun5 Oct 2017 10:17 AM ISTNew Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market anti-diuretic Desmopressin nasal spray...
Zydus Cadila gets USFDA nod to market HIV drug Ruby Khatun Khatun10 Aug 2017 9:30 AM ISTNew Delhi: Drug firm Zydus Cadila on Tuesday said it has received the tentative approval from the US health regulator to market Abacavir and...
Cadila Healthcare beats Lupin to become 2nd most valued pharma company in India Ruby Khatun Khatun8 Jun 2017 2:26 PM ISTNew Delhi: Shares of Cadila Healthcare surged nearly 10 per cent, helping the company overtake Lupin to become the second most valued pharma firm in...
Zydus Cadila gets USFDA nod to market alcohol abstinence drug Ruby Khatun Khatun29 May 2017 11:56 AM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market Acamprosate calcium delayed-release tablets used for...
Zydus Cadila gets USFDA nod for anti-cholesterol drug Ruby Khatun Khatun1 May 2017 9:40 AM ISTNew Delhi: Drug firm Zydus Cadila has received approval from the US health regulator to market an anti-cholesterol drug, Cholestyramine, in the...
Indian Pharma companies biggest violators of USFDA integrity norms Geeta Sharma Sharma7 May 2016 3:35 PM IST Mumbai:Sixty percent of reported data integrity violations in the records of US regulator since 2011 are against drug manufacturing units in...
